5.895USD+0.43%Mkt Cap: 40.54M USDP/E: 0.27Last update: 2026-06-01
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. The company's lead radiotherapeutic candidate is rh…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap40.54M USD
Enterprise Value32.15M USD
Revenue (TTM)5.21M USD
Gross Profit-3.17M USD
Net Income (TTM)-22.39M USD
Revenue/Share1.675 USD
Last Price5.895 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees28
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS72941H4002
Valuation
P/E (Trailing)0.27
P/E (Forward)-2.46
PEG2.45
EV/EBITDA-2.16
EV/Revenue6.17
P/S7.68
P/B8.08
EPS (TTM)21.56
EPS (Forward)-2.37
52W Range
2.90015% of range23.50
52W High23.50 USD
52W Low2.900 USD
Profitability
Gross Margin-60.73%
Oper. Margin-420.04%
EBITDA Margin-284.92%
Profit Margin0.00%
ROE-560.21%
ROA-137.13%
Growth
Revenue Growth-3.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-20.77M USD
CapEx (TTM)67.00K USD
FCF Margin-260.84%
FCF Yield-33.54%
Net Debt-7.79M USD
Net Debt/EBITDA0.52
Balance Sheet
Debt/Equity0.21
Current Ratio1.23
Quick Ratio0.73
Book Value/Sh0.7200 USD
Cash/Share1.255 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateAug 6, 2019
Splits
Last Split1:25
Split DateApr 2, 2026
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)38.00 USD
Target Range12.00 USD – 65.00 USD
# Analysts4
Ownership
Shares Out.6.88M
Float6.46M
Insiders1.45%
Institutions10.38%
Short Interest
Short Ratio5.4d
Short % Float16.95%
Short % Out.16.89%
Shares Short1.16M
Short (prev mo.)1.35M
Technical
SMA 505.764 (+2.3%)
SMA 20010.49 (-43.8%)
Beta1.40
S&P 52W Chg27.70%
Avg Vol (30d)183.13K
Avg Vol (10d)175.52K
Technical Indicators
RSI (14)46.5
MACD0.1082
MACD Signal0.0927
MACD Hist.+0.0155
BB Upper6.913 USD
BB Middle6.121 USD
BB Lower5.329 USD
BB Width25.88%
ATR (14)0.6077 USD
Vol Ratio (20d)1.06x